Increased hepatic cell proliferation and lung abnormalities in mice deficient in CCAAT/enhancer binding protein alpha
about
Repression of transcriptional activity of C/EBPalpha by E2F-dimerization partner complexesThe CCAAT enhancer-binding protein alpha (C/EBPalpha) requires a SWI/SNF complex for proliferation arrestDefective adipocyte differentiation in mice lacking the C/EBPbeta and/or C/EBPdelta gene.CCAAT/enhancer-binding proteins: structure, function and regulationC/EBPalpha regulates formation of S-phase-specific E2F-p107 complexes in livers of newborn micePrevalence and prognostic implications of CEBPA mutations in pediatric acute myeloid leukemia (AML): a report from the Children's Oncology GroupCCAAT/enhancer binding protein alpha uses distinct domains to prolong pituitary cells in the growth 1 and DNA synthesis phases of the cell cycleAdipogenesisC/EBPalpha is required for differentiation of white, but not brown, adipose tissueNovel combinatorial interactions of GATA-1, PU.1, and C/EBPepsilon isoforms regulate transcription of the gene encoding eosinophil granule major basic proteinInflammation and cellular stress: a mechanistic link between immune-mediated and metabolically driven pathologiesIntestinal maturation in mice lacking CCAAT/enhancer-binding protein alpha (C/EPBalpha)Inactivation of the winged helix transcription factor HNF3alpha affects glucose homeostasis and islet glucagon gene expression in vivoImpairment of natural killer cytotoxic activity and interferon gamma production in CCAAT/enhancer binding protein gamma-deficient miceLipogenesis in fetal rat lung: importance of C/EBPalpha, SREBP-1c, and stearoyl-CoA desaturaseKeratinocyte growth factor and the transcription factors C/EBP alpha, C/EBP delta, and SREBP-1c regulate fatty acid synthesis in alveolar type II cellsMitochondrial biogenesis and thyroid status maturation in brown fat require CCAAT/enhancer-binding protein alphaThe SWI/SNF chromatin-remodeling complex subunit SNF5 is essential for hepatocyte differentiationFunctional sequestration of transcription factor activity by repetitive DNAAnalysis of the Xenopus laevis CCAAT-enhancer binding protein alpha gene promoter demonstrates species-specific differences in the mechanisms for both auto-activation and regulation by Sp1.Mice with a deletion in the gene for CCAAT/enhancer-binding protein beta have an attenuated response to cAMP and impaired carbohydrate metabolism.Liver-enriched transcription factors are critical for the expression of hepatocyte marker genes in mES-derived hepatocyte-lineage cells.Gene expression profiling and network analysis reveals lipid and steroid metabolism to be the most favored by TNFalpha in HepG2 cells.The C/EBP family of transcription factors in the liver and other organs.Multiple functional domains of AML1: PU.1 and C/EBPalpha synergize with different regions of AML1CCAAT/enhancer binding protein alpha is a regulatory switch sufficient for induction of granulocytic development from bipotential myeloid progenitorsDephosphorylated C/EBPalpha accelerates cell proliferation through sequestering retinoblastoma protein.Hypoglycemia and impaired hepatic glucose production in mice with a deletion of the C/EBPbeta gene.Tob1 is a constitutively expressed repressor of liver regenerationc-Myc is a critical target for c/EBPalpha in granulopoiesis.Propranolol promotes accelerated and dysregulated adipogenesis in hemangioma stem cells.The Cebpa +37-kb enhancer directs transgene expression to myeloid progenitors and to long-term hematopoietic stem cells.C/EBPalpha triggers proteasome-dependent degradation of cdk4 during growth arrestrtTA toxicity limits the usefulness of the SP-C-rtTA transgenic mouseRespiratory failure due to differentiation arrest and expansion of alveolar cells following lung-specific loss of the transcription factor C/EBPalpha in mice.Downregulation of c-Jun expression by transcription factor C/EBPalpha is critical for granulocytic lineage commitmentmiR-511 and miR-1297 inhibit human lung adenocarcinoma cell proliferation by targeting oncogene TRIB2.Epigenetic modulation of tumor suppressor CCAAT/enhancer binding protein alpha activity in lung cancer.Cyclin D3 maintains growth-inhibitory activity of C/EBPalpha by stabilizing C/EBPalpha-cdk2 and C/EBPalpha-Brm complexes.Specific activin receptor-like kinase 3 inhibitors enhance liver regeneration
P2860
Q24300598-8BF1E19D-3C96-4021-8397-D39489E049B9Q24301285-0CC91988-CBFA-401B-9BF8-645D84D39EB2Q24532889-193D6183-16AC-4062-A1F1-BD8942661BF5Q24534323-D7E089BF-51A2-4ADF-9DC4-BD12C8BE3202Q24554514-C96BE578-C125-451D-89E7-6EE278581E87Q24602856-9BBA52D3-D882-4DD0-A06F-0E77899FC812Q24805510-E256916F-CEF9-47B9-8D07-3508474332E5Q26828614-18E1B1E6-DC05-4CCE-9964-83454B85F4F3Q28199288-71EB5E18-C05E-492C-B152-E866CB901224Q28219413-01EB33E3-A072-4FD4-BFC3-0AF7C0D064D1Q28236897-81FE0872-F311-4CE9-89DE-4972250AB339Q28506079-A283E6BC-B261-47FB-9549-2D0680D174EFQ28507284-6FF13ECF-A9C4-4825-8E8D-2A75D23A8024Q28510979-9B037D1E-5174-4C18-B607-8C4BF0130F07Q28580466-1FB496BF-795C-4525-8FB3-EB1934A2A378Q28580518-203A3AB9-217B-49A5-8D13-0C616AC4134EQ28589833-3E142ADC-44CE-4EAF-A812-D8392E40AA06Q28589887-7C5C0F2D-9C93-4C6E-82F0-F3B8E2A49D02Q30416705-4D918359-83D2-4CE1-95F5-6F9B54CCB18BQ30977591-9C87CF2B-F08E-4AB2-998C-0F20009F4AC8Q31451911-175CB806-ECDC-445B-9594-5541B2CD0BC1Q33434187-2D13797B-249E-4B19-A838-2985FD7130ADQ33530117-680221B1-EBD6-4474-BDD0-FF5AA5A63170Q33630431-F49F3D68-9843-4EAE-88F9-E896CA53A949Q33774804-1157C404-9D55-4F8A-BAB9-EFEDDAB0197CQ33775064-E308547D-41BE-4422-ADF0-27F46DD4B82AQ33823969-6B1F8CFA-F7DC-441C-AB28-7DD363331E23Q33834864-87C1D8A2-C6D5-4451-9239-886D39311AD6Q33902409-7D256331-AFB1-4EE0-8EAD-B00574704B39Q33968356-DF3BAB0C-AFF1-40AD-A122-F2C9C27608C5Q34050131-7C84B2DE-267E-4BAA-8F93-FDCCEE007B3DQ34066703-72385C1A-0B5F-4703-9DB4-0E22A112DFE6Q34086004-4AF42550-E988-4813-88CD-1C79D65E9DA1Q34201757-558D0562-9CA3-47B6-8EC4-3299C6717EDCQ34302408-B34D78EA-5405-44CC-BBA1-7674E83ED417Q34443338-73166F57-CB50-41B0-AD0D-FF2ED795A35BQ34446954-750F9B5A-685C-4FFA-B609-077BAB530EEEQ34502198-1191D944-E515-4815-9B23-BDF397AC02A7Q34520031-30C38F87-7327-4C4D-9E9A-7D5A9D210F1EQ34573900-DBF9B605-47B7-4F31-B35F-B4B69E1C2350
P2860
Increased hepatic cell proliferation and lung abnormalities in mice deficient in CCAAT/enhancer binding protein alpha
description
1996 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1996 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
article publié dans la revue scientifique Journal of Biological Chemistry
@fr
artículu científicu espublizáu en 1996
@ast
im Oktober 1996 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 1996/10/04)
@sk
vědecký článek publikovaný v roce 1996
@cs
wetenschappelijk artikel (gepubliceerd op 1996/10/04)
@nl
наукова стаття, опублікована в жовтні 1996
@uk
name
Increased hepatic cell prolife ...... enhancer binding protein alpha
@ast
Increased hepatic cell prolife ...... enhancer binding protein alpha
@en
Increased hepatic cell prolife ...... enhancer binding protein alpha
@nl
type
label
Increased hepatic cell prolife ...... enhancer binding protein alpha
@ast
Increased hepatic cell prolife ...... enhancer binding protein alpha
@en
Increased hepatic cell prolife ...... enhancer binding protein alpha
@nl
prefLabel
Increased hepatic cell prolife ...... enhancer binding protein alpha
@ast
Increased hepatic cell prolife ...... enhancer binding protein alpha
@en
Increased hepatic cell prolife ...... enhancer binding protein alpha
@nl
P2093
P2860
P356
P1476
Increased hepatic cell prolife ...... enhancer binding protein alpha
@en
P2093
H. Kylefjord
K. G. Xanthopoulos
L. Ahrlund-Richter
P2860
P304
24753–24760
P356
10.1074/JBC.271.40.24753
P407
P577
1996-10-04T00:00:00Z